| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |